ACTG — Acacia Research Income Statement
0.000.00%
- $300.75m
- $118.77m
- $122.31m
- 63
- 55
- 36
- 51
Annual income statement for Acacia Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 29.8 | 88 | 59.2 | 125 | 122 |
Cost of Revenue | |||||
Gross Profit | 22.4 | 79.3 | 38 | 105 | 52.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 49.3 | 73.5 | 99.3 | 104 | 170 |
Operating Profit | -19.5 | 14.5 | -40.1 | 20.9 | -47.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 108 | 175 | -127 | 67.4 | -38.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 109 | 150 | -111 | 68.9 | -34.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 109 | 149 | -125 | 67.1 | -36.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 86.8 | 188 | -133 | 55.1 | -36.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.58 | 1.96 | -3.07 | 0.672 | -0.237 |